The efficacy and safety of eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria. Results of a phase III randomized open-label comparative clinical trial - PDF (Russian)
Copyright (c) 2021 Consilium Medicum

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.